Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Lymphotoxin-alpha gene 252A>G and metabolic syndrome features in Korean men with coronary artery disease.

Jang Y, Kim HJ, Koh SJ, Hyun YJ, Chae JS, Cho H, Ha JW, Kim BK, Kim JS, Lee JH.

Clin Chim Acta. 2007 Sep;384(1-2):124-8. Epub 2007 Jul 4.

PMID:
17640627
2.

Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis.

Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Cho H, Lee JH.

Clin Chim Acta. 2006 Aug;370(1-2):63-71. Epub 2006 Mar 10.

PMID:
16530178
3.

Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations.

Kimura A, Takahashi M, Choi BY, Bae SW, Hohta S, Sasaoka T, Nakahara KI, Chida K, Sawabe M, Yasunami M, Naruse T, Izumi T, Park JE.

Tissue Antigens. 2007 Mar;69(3):265-9.

PMID:
17493152
4.

Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy.

Ramasawmy R, Fae KC, Cunha-Neto E, Müller NG, Cavalcanti VL, Ferreira RC, Drigo SA, Ianni B, Mady C, Goldberg AC, Kalil J.

J Infect Dis. 2007 Dec 15;196(12):1836-43. doi: 10.1086/523653.

PMID:
18190265
5.
6.

The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women.

Jang Y, Chae JS, Koh SJ, Hyun YJ, Kim JY, Jeong YJ, Park S, Ahn CM, Lee JH.

Clin Chim Acta. 2008 May;391(1-2):85-90. doi: 10.1016/j.cca.2008.02.011. Epub 2008 Feb 16.

PMID:
18328815
7.

Effect of the 252A>G polymorphism of the lymphotoxin-alpha gene on inflammatory markers of response to cigarette smoking in Korean healthy men.

Jang Y, Koh SJ, Kim OY, Kim BK, Choi D, Hyun YJ, Kim HJ, Chae JS, Lee JH.

Clin Chim Acta. 2007 Feb;377(1-2):221-7. Epub 2006 Oct 7. Erratum in: Clin Chim Acta. 2007 Apr;379(1-2):179.

PMID:
17113059
8.

Lymphotoxin alpha LTA+496C allele is a risk factor for periodontitis in patients with coronary artery disease.

Palikhe A, Lokki ML, Pussinen PJ, Paju S, Ahlberg J, Asikainen S, Seppänen M, Valtonen V, Nieminen MS, Sinisalo J.

Tissue Antigens. 2008 Jun;71(6):530-7. doi: 10.1111/j.1399-0039.2008.01038.x. Epub 2008 Apr 2.

PMID:
18384488
9.

Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease.

Jang Y, Kim OY, Hyun YJ, Chae JS, Koh SJ, Heo YM, Choi D, Shin DJ, Huttner K, Lee JH.

Transl Res. 2008 Mar;151(3):154-61. doi: 10.1016/j.trsl.2007.11.004. Epub 2008 Jan 2.

PMID:
18279814
10.

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.

Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, Girelli D, Friso S, Pignatti PF, Corrocher R.

J Lipid Res. 2003 Dec;44(12):2374-81. Epub 2003 Oct 16.

11.

Association between Lymphotoxin Alpha (-252G/A and -804C/A) Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-Analysis.

Kumar P, Misra S, Kumar A, Kishor Pandit A, Chakravarty K, Prasad K.

Acta Neurol Taiwan. 2016 Mar;25(1):10-7.

12.

The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.

Jang Y, Chae JS, Hyun YJ, Koh SJ, Kim JY, Ko MJ, Rim SJ, Shin HJ, Ordovas JM, Lee JH.

Clin Sci (Lond). 2007 Oct;113(8):349-56.

PMID:
17504241
13.

Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population. The Fukuoka Stroke Registry and the Hisayama Study.

Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M.

Cerebrovasc Dis. 2008;25(5):417-22. doi: 10.1159/000121342. Epub 2008 Mar 17.

PMID:
18349535
14.

Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese.

Yamada A, Ichihara S, Murase Y, Kato T, Izawa H, Nagata K, Murohara T, Yamada Y, Yokota M.

J Mol Med (Berl). 2004 Jul;82(7):477-83. Epub 2004 Jun 3.

PMID:
15175864
15.

Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease.

Zou Y, Hu D, Yang X, Jia X, Wang L, Cui L, Liu X, Gao M, Wei Y, Xu Z.

Chin Med J (Engl). 2003 May;116(5):665-8.

PMID:
12875674
16.

Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis.

Saely CH, Risch L, Hoefle G, Rein P, Muendlein A, Marte T, Aczel S, Langer P, Drexel H.

Clin Chim Acta. 2007 Aug;383(1-2):97-102. Epub 2007 May 10.

PMID:
17550784
17.

Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.

Krecki R, Drozdz J, Szcześniak P, Orszulak-Michalak D, Krzemińska-Pakuła M.

Kardiol Pol. 2008 Nov;66(11):1173-80; discussion 1181-2.

PMID:
19105094
18.

Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.

Liang KW, Lee WJ, Lee WL, Chen YT, Ting CT, Sheu WH.

Clin Chim Acta. 2008 Feb;388(1-2):41-5. Epub 2007 Oct 10.

PMID:
17967444
19.

Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease.

Ntyintyane LM, Panz VR, Raal FJ, Gill GV.

QJM. 2008 Feb;101(2):111-9. doi: 10.1093/qjmed/hcm137. Epub 2008 Jan 14.

PMID:
18194974
20.

Supplemental Content

Support Center